Categories: News

Reverence Emerges from Stealth, Introduces Digital Health Platform to Operationalize Clinically Effective Home-Based Care at Scale

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

The company launches with $9.5M in initial funding led by Target Global

NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) — Reverence, a digital health company reinventing how in-home care is managed, today emerged from stealth with an initial raise of $9.5M led by Target Global. The company has also acquired an AI-powered staffing platform, Hirehand, providing both a key building block and an immediate opportunity to improve the management of home-based care services.

The pandemic, coupled with an aging U.S. population, has ignited a major shift in where and how care is delivered. Healthcare is increasingly transitioning from traditional facilities to in-home models due to patient preference and improvements in remote care models. Yet even as home-based care has become more popular, an acute shortage of caregivers, coupled with challenges coordinating across paid and family support, have limited the industry’s ability to realize the full potential of home care.

“We’ve only scratched the surface of how home-based care models can improve and save lives,” said Lee Hudson Teslik, founder and CEO of Reverence. “Our technology provides the connective tissue needed to bridge the gap between hospital and home—unlocking new possibilities and paving the way to a stronger, more sustainable, and more clinically effective future for home-based care.”

Reverence’s digital-first product suite streamlines and improves the end-to-end experience for the home care ecosystem—including patients, family caregivers, clinical and non-clinical practitioners, and provider groups. At the core of this platform is Hirehand’s unique staffing product, which leverages artificial intelligence to help provider groups optimize who they send into a patient’s home and when—better matching carers to patients and increasing coverage of market demand.

In addition to improving practitioner satisfaction and retention, Reverence provides tools and training to maximize practitioner impact on patient health and well-being. For example, the platform powers data-sharing across all practitioners entering the home, including family caregivers, and provides condition-specific checklists supporting more rigorous and clinically-sound in-home care plans.

In the coming months, Reverence will expand its offerings with a focus on guiding clinically sound and financially sustainable care models. Family members will have the opportunity to integrate their insights and observations alongside input from paid practitioners to inform the best possible care plan and improve patient outcomes.

“Lee and the Reverence team have identified an incredible opportunity to transform a rapidly growing industry at a critical time,” said Dr. Ricardo Schafer, Partner at Target Global. “As it stands, the home health industry is not equipped to provide clinically effective care at scale; but Reverence is changing that. We’re honored to join them on their mission to raise the quality and dignity of home-based care.”

The capital raised will enable Reverence to advance its end-to-end suite of products, build an expert team of care advocates, and deepen its clinical impact.

For more information visit http://reverencecare.com

About Reverence
Reverence is a digital health company reinventing how in-home care is managed. Reverence combines technology and data with a people-first approach that benefits the entire care ecosystem: caregivers, patients + families, and provider groups. Reverence’s digital-first platforms and tools operationalize clinically effective home-based care at scale. To learn more, visit reverencecare.com.

Media Contact
Natalie Younger
LaunchSquad for Reverence
reverence@launchsquad.com

Staff

Recent Posts

rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares

FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or…

2 hours ago

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 â€“ Novo Nordisk today announced that the US Food and Drug…

2 hours ago

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No WarrantsLos Angeles, CA, Aug.…

2 hours ago

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical…

2 hours ago

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or…

2 hours ago